228 episodes

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerVoice Internal Medicine Audio PeerVoice

    • Science
    • 4.5 • 2 Ratings

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

    Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights from 2021 Virtual Congresses

    Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights from 2021 Virtual Congresses

    Visit https://www.peervoice.com/DZZ860 to view the entire programme with slides. After completing “Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights from 2021 Virtual Congresses”, participants will be able to: Summarise the latest clinical evidence for managing patients with NSCLC with MET exon 14 (METex14) skipping mutations; Describe the strengths and limitations of these data within the context of current clinical practice.

    • 5 min
    Shifting the Treatment Paradigm in Type 2 Diabetes and CKD: The Role of Nonsteroidal MRAs

    Shifting the Treatment Paradigm in Type 2 Diabetes and CKD: The Role of Nonsteroidal MRAs

    Visit https://www.peervoice.com/GMF860 to view the entire programme with slides. After completing “Shifting the Treatment Paradigm in Type 2 Diabetes and CKD: The Role of Nonsteroidal MRAs”, participants will be able to: Evaluate recent clinical data for novel strategies for the management of type 2 diabetes (T2DM) and chronic kidney disease (CKD); Identify patient and disease characteristics that may influence treatment decision-making for patients with T2DM and CKD; Translate current and emerging clinical evidence into optimal treatment plans for patients with T2DM and CKD.

    • 10 min
    Seeking a More Positive Outlook in Patients With mTNBC? Treatment Advances and How to Apply Them

    Seeking a More Positive Outlook in Patients With mTNBC? Treatment Advances and How to Apply Them

    Visit https://www.peervoice.com/UHN860 to view the entire programme with slides. After completing “Seeking a More Positive Outlook in Patients With mTNBC? Treatment Advances and How to Apply Them”, participants will be able to: Describe the efficacy and safety data for recent treatment options for metastatic triple-negative breast cancer (mTNBC); Evaluate the clinical implications of the evidence for new treatments on real-life practices; Identify which patients are most likely to benefit from the new treatment options, such as the TROP2-directed antibody drug-conjugate (ADC) therapies.

    • 24 min
    The Need for Speed: Improving Diagnostic Accuracy and Effective Management of aTTP in Emergency and Intensive Care

    The Need for Speed: Improving Diagnostic Accuracy and Effective Management of aTTP in Emergency and Intensive Care

    Visit https://www.peervoice.com/CGV860 to view the entire programme with slides. After completing “The Need for Speed: Improving Diagnostic Accuracy and Effective Management of aTTP in Emergency and Intensive Care”, participants will be able to: Discuss the importance of efficient and effective identification and initiation of therapy in patients with suspected acquired thrombotic thrombocytopenic purpura (aTTP); Explain recent guidelines on diagnosis and initial management of patients with aTTP in the emergency department/intensive care unit (ED/ICU); Apply evidence- and expert-based guidance in the management of aTTP.

    • 1 hr 21 min
    The Cancer No One Wants to Talk About: Squamous Cell Carcinoma of the Anal Canal

    The Cancer No One Wants to Talk About: Squamous Cell Carcinoma of the Anal Canal

    Visit https://www.peervoice.com/TFW860 to view the entire programme with slides. After completing “The Cancer No One Wants to Talk About: Squamous Cell Carcinoma of the Anal Canal”, participants will be able to: Recognise the stigma associated with squamous cell carcinoma of the anal canal (SCAC); Describe the typical presentation and treatment of a patient with SCAC; Develop strategies to facilitate talking to patients about SCAC.

    • 19 min
    Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors

    Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors

    Visit https://www.peervoice.com/KAN860 to view the entire programme with slides. After completing “Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors”, participants will be able to: Explain the most recent clinical evidence for SGLT2 inhibitors for the management of patients with heart failure (HF) and associated guidelines; Evaluate how these clinical data add to previous knowledge about the management of HF; Discuss the clinical implications of the guidelines and data in the context of current HF treatment paradigms.

    • 12 min

Customer Reviews

4.5 out of 5
2 Ratings

2 Ratings

Top Podcasts In Science

You Might Also Like

More by PeerVoice